The tachykinin NK1 receptor antagonist CP-99,994 attenuates cisplatin induced emesis in the ferret
- 1 November 1993
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 250 (1) , R5-R6
- https://doi.org/10.1016/0014-2999(93)90649-3
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Neurotransmitter functions of mammalian tachykinins.Physiological Reviews, 1993
- Pharmacology of CP-99,994; a nonpeptide antagonist of the tachykinin NK1 receptorRegulatory Peptides, 1992
- Ondansetron Compared with High-Dose Metoclopramide in Prophylaxis of Acute and Delayed Cisplatin-Induced Nausea and VomitingAnnals of Internal Medicine, 1990
- Neuropharmacology of emesis induced by anti-cancer therapyTrends in Pharmacological Sciences, 1988
- PREVENTION OF EMESIS IN PATIENTS RECEIVING CYTOTOXIC DRUGS BY GR38032F, A SELECTIVE 5-HT3 RECEPTOR ANTAGONISTThe Lancet, 1987
- 5-hydroxytryptamine m-receptor antagonism to prevent cisplatin-induced emesisNeuropharmacology, 1986
- Inhibition of cisplatin‐induced vomiting by selective 5‐hydroxytryptamine M‐receptor antagonismBritish Journal of Pharmacology, 1986